Publications by authors named "Doaa Aljefri"

Claim this Profile
C
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant Infections: A Multicenter Cohort Study.
Thamer A Almangour, Zakiyah Alkherb, Leen Ghonem, Mohammed Al Musawa, Abdullah Almohaizeie, Doaa Aljefri

Pharmaceuticals (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study.
Thamer A Almangour, Leen Ghonem, Dareen Alassiri, Alanoud Aljurbua, Mohammed Al Musawa, Doaa Aljefri

J Infect Chemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Actual and Rounded Serum Creatinine Concentration for Assessing the Accuracy of Vancomycin Dosing in Elderly Patients: A Single-Center Retrospective Study.
Rawan Bukhari, Hani Hasan, Doaa Aljefri, Rawan Rambo, Ghusun AlSenaini

Healthcare (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study.
Thamer A Almangour, Leen Ghonem, Dareen Alassiri, Alanoud Aljurbua, Mohammed Al Musawa, Doaa Aljefri

Antimicrob Agents Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Bictegravir-Based Regimen in Pregnant Women Living with HIV: A Case Report.
Shaimaa Alsulami, Sultan N Alotaibi, Nader Damfu, Doaa M Aljefri, Hadeel Ahmed Altayib

J Int Assoc Provid AIDS Care· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious diseases pharmacy practice, education, and research in Saudi Arabia: A review and future perspectives by the Infectious Diseases Pharmacy Specialty Network at the Saudi Society of Clinical Pharmacy.
Yazed Saleh Alsowaida, Abrar K Thabit, Thamer A Almangour, Khalid Bin Saleh, Ahmad Mahrous, Doaa Aljefri

Saudi Pharm J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence.
Yahya A Mohzari, Ahmad Alamer, Majda Alattas, Ahmed A Alrashed, Nura A Alshehab, Doaa Aljefri

Expert Rev Anti Infect Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.
Doaa M Aljefri, Sean N Avedissian, Nathaniel J Rhodes, Michael J Postelnick, Kevin Nguyen

Clin Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections.
Gerald Elliott, Michael Malczynski, Viktorjia O Barr, Doaa Aljefri, David Martin

BMC Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).
Sean N Avedissian, Nathaniel J Rhodes, Jiajun Liu, Doaa Aljefri, Michael J Postelnick

Antimicrob Agents Chemother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis